Event Title

Design and Synthesis of Emtricitabine Analogs as Potential Treatments for HIV

Session Number

Project ID: CHEM 15

Advisor(s)

Dr. John Thurmond, Illinois Mathematics and Science Academy

Discipline

Chemistry

Start Date

20-4-2022 10:25 AM

End Date

20-4-2022 10:40 AM

Abstract

Emtricitabine is a drug used to treat Human Immunodeficiency Virus Infection by slowing the progression of the virus in the body. Previously, a compound with a better binding affinity that was designed using computer aided drug design was found. The goal of this study is to synthesize the compound in the lab and test the product produced. The chemical synthesis is currently in progress. The newly designed drugs showed better binding affinity than emtricitabine and could lead to development of new HIV drugs.

Share

COinS
 
Apr 20th, 10:25 AM Apr 20th, 10:40 AM

Design and Synthesis of Emtricitabine Analogs as Potential Treatments for HIV

Emtricitabine is a drug used to treat Human Immunodeficiency Virus Infection by slowing the progression of the virus in the body. Previously, a compound with a better binding affinity that was designed using computer aided drug design was found. The goal of this study is to synthesize the compound in the lab and test the product produced. The chemical synthesis is currently in progress. The newly designed drugs showed better binding affinity than emtricitabine and could lead to development of new HIV drugs.